Literature DB >> 16771936

Esophagitis: incidence and risk of esophageal adenocarcinoma--a population-based cohort study.

Annmarie Lassen1, Jesper Hallas, Ove B Schaffalitzky de Muckadell.   

Abstract

OBJECTIVES: Although symptoms of reflux are common, our knowledge of the epidemiology and natural history of gastroesophageal reflux disease is sparse. The risk of esophageal adenocarcinoma is increased among patients with acid reflux, but the contribution of Barrett's lesions is unknown.
METHODS: With the aim to estimate the incidence of diagnosed endoscopic esophagitis lesions and the risk of esophageal adenocarcinoma among patients with previously diagnosed esophagitis, we extracted data on endoscopies, esophagitis diagnoses, and gastroesophageal cancer diagnoses from five population-based databases covering the period from 1974 to 2002, and covering all citizens in Funen County (population 470,000).
RESULTS: In 2002, the incidence of esophagitis lesions was 2.4 per 1,000 person-years (95% confidence interval 2.3-2.6), 18.3 per 1,000 persons (17.9-18.7) had previously diagnosed esophagitis. Incidence increased by calendar year and age, was higher among males than among females, and was closely related to rate of endoscopy. Among 11,129 patients with previously diagnosed esophagitis, 15 had esophageal adenocarcinoma during 58,322 person-years of follow-up (26 per 100,000 person-years). The expected number was 2.79 and the standardized incidence ratio was 5.38 (3.01-8.87). Ten of the 15 patients with esophageal adenocarcinoma had previously diagnosed Barrett's esophagus.
CONCLUSION: The risk of esophageal adenocarcinoma is increased fivefold in patients with previously diagnosed esophagitis, but most of the adenocarcinomas occurred among patients with Barrett's esophagus.

Entities:  

Mesh:

Year:  2006        PMID: 16771936     DOI: 10.1111/j.1572-0241.2006.00550.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  20 in total

1.  Shape of Barrett's epithelium is associated with prevalence of erosive esophagitis.

Authors:  Tomoyuki Akiyama; Masahiko Inamori; Hiroshi Iida; Hiroki Endo; Kunihiro Hosono; Yasunari Sakamoto; Koji Fujita; Masato Yoneda; Hirokazu Takahashi; Tomoko Koide; Chikako Tokoro; Ayumu Goto; Yasunobu Abe; Takeshi Shimamura; Noritoshi Kobayashi; Kensuke Kubota; Satoru Saito; Atsushi Nakajima
Journal:  World J Gastroenterol       Date:  2010-01-28       Impact factor: 5.742

2.  A Comparison Study of Esophageal Findings on (18)F-FDG PET/CT and Esophagogastroduodenoscopy.

Authors:  KwanHyeong Jo; Soyoung Kim; Jongtae Cha; Sang Hyun Hwang; Narae Lee; Mijin Yun; Won Jun Kang
Journal:  Nucl Med Mol Imaging       Date:  2015-10-16

Review 3.  Endoscopic risk factors for neoplastic progression in patients with Barrett's oesophagus.

Authors:  Angela Bureo Gonzalez; Jacques Jghm Bergman; Roos E Pouw
Journal:  United European Gastroenterol J       Date:  2016-03-02       Impact factor: 4.623

4.  Exposure to oral bisphosphonates and risk of gastrointestinal cancer.

Authors:  D Choi; S Choi; J Chang; S M Park
Journal:  Osteoporos Int       Date:  2020-02-07       Impact factor: 4.507

Review 5.  Bisphosphonates and esophageal cancer--a pathway through the confusion.

Authors:  William G Dixon; Daniel H Solomon
Journal:  Nat Rev Rheumatol       Date:  2011-05-03       Impact factor: 20.543

6.  Interactions between genetic polymorphisms in the apoptotic pathway and environmental factors on esophageal adenocarcinoma risk.

Authors:  I-Chen Wu; Yang Zhao; Rihong Zhai; Chen-yu Liu; Feng Chen; Monica Ter-Minassian; Kofi Asomaning; Li Su; Rebecca S Heist; Matthew H Kulke; Geoffrey Liu; David C Christiani
Journal:  Carcinogenesis       Date:  2011-01-06       Impact factor: 4.944

7.  Prevalence of Barrett's esophagus in patients with moderate to severe erosive esophagitis.

Authors:  Nooman Gilani; Richard-D Gerkin; Francisco-C Ramirez; Shahina Hakim; Adam-C Randolph
Journal:  World J Gastroenterol       Date:  2008-06-14       Impact factor: 5.742

8.  Notch signaling drives stemness and tumorigenicity of esophageal adenocarcinoma.

Authors:  Zhiqiang Wang; Thiago G Da Silva; Ke Jin; Xiaoqing Han; Prathibha Ranganathan; Xiaoxia Zhu; Avencia Sanchez-Mejias; Feng Bai; Bin Li; Dennis Liang Fei; Kelly Weaver; Rodrigo Vasquez-Del Carpio; Anna E Moscowitz; Vadim P Koshenkov; Lilly Sanchez; Lynne Sparling; Xin-Hai Pei; Dido Franceschi; Afonso Ribeiro; David J Robbins; Alan S Livingstone; Anthony J Capobianco
Journal:  Cancer Res       Date:  2014-08-27       Impact factor: 12.701

9.  Endoscopic cardial constriction with band ligation in the treatment of refractory gastroesophageal reflux disease: a preliminary feasibility study.

Authors:  Zhi-Tong Li; Feng Ji; Xin-Wei Han; Rui Zhang; Li-Dong Chen; Chun-Xia Li; Li-Li Yuan; Zhong-Gao Wang; Kang-Dong Liu
Journal:  Surg Endosc       Date:  2021-04-21       Impact factor: 4.584

10.  A higher dosage of oral alendronate will increase the subsequent cancer risk of osteoporosis patients in Taiwan: a population-based cohort study.

Authors:  Wen-Yuan Lee; Li-Min Sun; Ming-Chia Lin; Ji-An Liang; Shih-Ni Chang; Fung-Chang Sung; Chih-Hsin Muo; Chia-Hung Kao
Journal:  PLoS One       Date:  2012-12-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.